Furthermore, mutations in DNMT3A and TET2 are frequently observed in AML (Ley et al., 2010) and to a lesser degree also in multiple myeloma (Dupere-Richer and Licht, 2017). This evidence concerns the gene DNMT3A and acute myeloid leukemia.